Brain stent blood thinner study pulled before it began

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria 1. Males or females between 35 and 80 years of age. 2. Symptomatic intracranial arteriosclerosis stenosis with reference diameter 2.25-4.00mm;. 3. Intracranial artery stenosis (≥70%) conformed by DSA. 4. Subjects who voluntarily participate in the study and sign informed consent form. Exclusion Criteria: 1. Subjects who have surgery within previous 30 days or plan to perform major surgery in the next 90 days (surgery grade 3 and above). 2. Subjects of acute hemorrhagic stroke within 3 months. 3. Disabling stroke with a baseline mRS score ≥3. 4. Lesion artery with severe calcification and close neighbour stenosis. 5. Non-atherosclerotic diseases (e.g. arterial dissection, Moya Moya disease, vascular inflammatory lesions caused by infection, autoimmune diseases, post-irradiation, postpartum status; developmental or genetic abnormalities such as fibromuscular dysplasia, sickle cell anemia, suspected vasospasm). 6. The ischaemic event that is highly suspected to be due to vascular embolism from an extracranial arterial segment such as ipsilateral neck/chest arterial occlusion) or cardio embolism such as atrial fibrillation, mitral stenosis, left ventricular thrombus, patent foramen ovale, myocardial infarction within 6 weeks, etc. 7. More than 50% stenosis of the supplying artery of the lesion artery: 1) MCA severe stenosis (lesion artery) with more than 50% stenosis of ipsilateral ICA (supplying artery). 2) Basilar artery severe stenosis (lesion artery) with more than 50% stenosis of dominant VA (supplying artery) stenosis. 8. Accompanied by intracranial tumours or intracranial arteriovenous malformations. 9. The patient who is allergy response to heparin, aspirin, clopidogrel, rapamycin, contrast agents, anaesthetics, or drug eluted stent components. 10. Women who are pregnant or lactating. 11. Due to cognitive or emotional disorders or mental illness, the patient who cannot finish the follow-up. 12. Investigators consider the patient who is not suitable for enrolling in the present trial.